Cite
HARVARD Citation
Moroney, J. et al. (n.d.). 158P Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant OVCA. Immuno-oncology technology. p. . [Online].